Effects of levetiracetam on blood-brain barrier disturbances following hyperthermia-induced seizures in rats with cortical dysplasia

Life Sciences

Volumn 87, Issue 19-22, 2010, Pages 609-619

  Ahishali, Bulent ^a   Kaya, Mehmet ^a   Orhan, Nurcan ^b   Arican, Nadir ^a   Ekizoglu, Oguzhan ^c   Elmas, Imdat ^a   Kucuk, Mutlu ^b   Kemikler, Gonul ^a   Kalayci, Rivaze ^b   Gurses, Candan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Dr Sadi Konuk Training and Research Hospital   (Turkey)

Author keywords

Blood brain barrier; Levetiracetam; Seizures

Indexed keywords

ETIRACETAM; FLUORESCEIN SODIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; OCCLUDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD PRESSURE; CONTROLLED STUDY; CORTICAL DYSPLASIA; DRUG EFFECT; ELECTRON MICROSCOPY; FEMALE; GAMMA IRRADIATION; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; MORTALITY; NONHUMAN; PINOCYTOSIS; RAT; SEIZURE; SURVIVAL; TIGHT JUNCTION; WESTERN BLOTTING;

ANIMALS; ANTICONVULSANTS; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; FEMALE; FEVER; FLUORESCEIN; GAMMA RAYS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MICROSCOPY, ELECTRON; PIRACETAM; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TIGHT JUNCTIONS;

ANIMALIA; RATTUS;

EID: 78049450377     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.09.014     Document Type: Article

References (57)

1. Aronica E., Gorter J.A., Janseni G.H., van Veelen C.W., van Rijen P.C., Leenstra S., et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 2003, 118:417-429.
2. Brandt C., Glien M., Gastens A.M., Fedrowitz M., Bethmann K., Volk H.A., et al. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 2007, 53:207-221.
3. Cendes F., Andermann F., Dubeau F., Gloor P., Evans A., Jones-Gotman M., et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology 1993, 43:1083-1087.
4. Cervós-Navarro J., Sharma H.S., Westman J., Bongcam-Rudloff E. Glial reactions in the central nervous system following heat stress. Prog Brain Res 1998, 115:241-274.
5. Chen K., Baram T.Z., Soltesz I. Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits. Nat Med 1999, 5:888-994.
6. Cilio M.R., Bianchi R., Balestri M., Onofri A., Giovannini S., Di Capua M., et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res 2009, 86:66-71.
7. Collins J.J., Tudor C., Leonard J.M., Chuck G., Franz D.N. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. J Child Neurol 2006, 21:53-57.
8. Doheny H.C., Ratnaraj N., Whittington M.A., Jefferys J.G., Patsalos P.N. Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat. Epilepsy Res 1999, 34:161-168.
9. Dube C.M., Baram T.Z. Complex febrile seizures-an experimental model in immature rodents. Models of Seizures and Epilepsy 2006, 33-340. Elsevier Academic Press, Chapter 26. A. Pitkanen, P.A. Schwartzkroin, S.L. Moshe (Eds.).
10. Germano I.M., Zhang Y.F., Sperber E.F., Moshe S.L. Neuronal migration disorders increase susceptibility to hyperthermia-induced seizures in developing rats. Epilepsia 1996, 37:902-910.
11. Gower A.J., Hirsch E., Boehrer A., Noyer M., Marescaux C. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 1995, 22:207-213.
12. Gurses C., Ekizoglu O., Orhan N., Ustek D., Arican N., Ahishali B., et al. Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia. Brain Res 2009, 1281:71-83.
13. Hamati-Haddad A., Abou-Khalil B. Epilepsy diagnosis and localization in patients with antecedent childhood febrile convulsions. Neurology 1998, 50:917-922.
14. Ishimaru Y., Chiba S., Serikawa T., Sasa M., Inaba H., Tamura Y., et al. Effects of levetiracetam on hippocampal kindling in Noda epileptic rats. Brain Res 2010, 1309:104-109.
15. Kaminski R.M., Matagne A., Leclercq K., Gillard M., Michel P., Kenda B., et al. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 2008, 54:715-720.
16. Kasantikul V., Brown W.J., Oldendorf W.H., Crandall P.C. Ultrastructural parameters of limbic microvasculature in human psychomotor epilepsy. Clin Neuropathol 1983, 2:171-178.
17. Kaya M., Gurses C., Kalayci R., Ekizoglu O., Ahishali B., Orhan N., et al. Morphological and functional changes of blood-brain barrier in kindled rats with cortical dysplasia. Brain Res 2008, 1208:181-191.
18. Kiyatkin E.A., Sharma H.S. Permeability of the blood-brain barrier depends on brain temperature. Neuroscience 2009, 161:926-939.
19. Kiyatkin E.A., Brown P.L., Sharma H.S. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci 2007, 6:1242-1253.
20. Klitgaard H., Pitkänen A. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam. Epileptic Disorder 2003, 5(Supply 1):S9-S16.
21. Klitgaard H., Matagne A., Gobert J., Wülfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 1998, 353:191-206.
22. Kuteykin-Teplyakov K., Brandt C., Hoffmann K., Löscher W. Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus. Epilepsia 2009, 50:887-897.
23. 2+ transporters but control glucose-evoked granule recruitment. J Cell Sci 2005, 118:5647-5660.
24. Lin D.D., Roper S.N. In utero irradiation as a model of cortical dysplasia. Models of Seizures and Epilepsy 2006, 315-322. Elsevier Academic Pres, New York. A. Pitkanen, P.A. Schwartzkroin, S.L. Mosh (Eds.).
25. Löscher W., Hönack D. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 1993, 232:147-158.
26. Löscher W., Hönack D. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam. Epilepsia 2000, 41:1499-1506.
27. Löscher W., Hönack D., Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 1998, 284:474-479.
28. Łotowska J.M., Sobaniec-Łotowska M.E., Sendrowski K., Sobaniec W., Artemowicz B. Ultrastructure of the blood-brain barrier of the gyrus hippocampal cortex in an experimental model of febrile seizures and with the use of a new generation antiepileptic drug-topiramate. Folia Neuropathol 2008, 46:57-68.
29. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004, 101:9861-9866.
30. Marchi N., Guiso G., Caccia S., Rizzi M., Gagliardi B., Noé F., et al. Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development. Neurobiol Dis 2006, 24:429-442.
31. Marchi N., Angelov L., Masaryk T., Fazio V., Granata T., Hernandez N., et al. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 2007, 48:732-742.
32. Morimoto T., Nagao H., Sano N., Takahashi M., Matsuda H. Electroencephalographic study of rat hyperthermic seizures. Epilepsia 1991, 32:289-293.
33. Oh H.S., Lee M.C., Kim H.S., Lee J.S., Lee J.H., Kim M.K., et al. Pathophysiologic characteristics of balloon cells in cortical dysplasia. Childs Nerv Syst 2008, 24:175-183.
34. Pekny M., Stanness K.A., Eliasson C., Betsholtz C., Janigro D. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 1998, 22:390-400.
35. Porter B.E., Judkins A.R., Clancy R.R., Duhaime A., Dlugos D.J., Golden J.A. Dysplasia: a common finding in intractable pediatric temporal lobe epilepsy. Neurology 2003, 61:365-368.
36. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
37. Ransohoff R.M. Immunology: barrier to electrical storms. Nature 2009, 457:155-156.
38. Rippe B., Rosengren B.I., Carlsson O., Venturoli D. Transendothelial transport: the vesicle controversy. J Vasc Res 2002, 39:375-390.
39. Roch C., Leroy C., Nehlig A., Namer I.J. Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 2002, 43:325-335.
40. Roper S.N., Gilmore R.L., Houser C.R. Experimentally induced disorders of neuronal migration produce an increased propensity for electrographic seizures in rats. Epilepsy Res 1995, 21:205-219.
41. Scantlebury M.H., Ouellet P.L., Psarropoulou C., Carmant L. Freeze lesion-induced focal cortical dysplasia predisposes to atypical hyperthermic seizures in the immature rat. Epilepsia 2004, 45:592-600.
42. Schmidt D., Löscher W. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 2009, 9:47-52.
43. Schnitzer J.E., Liu J., Oh P. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem 1995, 270:14399-14404.
44. Seiffert E., Dreier J.P., Iven S., Bechmann I., Tomkins O., Heinemann U., et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004, 24:7829-7836.
45. Shinnar S., Berg A.T., Moshe S.L., Shinnar R. How long do new-onset seizures in children last?. Ann Neurol 2001, 49:659-664.
46. Shinnar S., Hesdorffer D.C., Nordli D.R., Pellock J.M., O'Dell C., Lewis D.V., et al. FEBSTAT Study Team. Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 2008, 71:170-176.
47. Sisodiya S.M., Martinian L., Scheffer G.L., van der Valk P., Cross J.H., Scheper R.J., et al. Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia 2003, 44:1388-1396.
48. Smyth M.D., Barbaro N.M., Baraban S.C. Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia. Epilepsy Res 2002, 50:251-264.
49. Stojic J., Stöhr H., Weber B.H. Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression. BMC Mol Biol 2007, 8:42-51.
50. Suenaga N., Ichiyama T., Kubota M., Isumi H., Tohyama J., Furukawa S. Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures. J Neurol Sci 2008, 266:126-130.
51. Toth Z., Yan X.X., Haftoglou S., Ribak C.E., Baram T.Z. Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J Neurosci 1998, 18:4285-4294.
52. Ueda Y., Doi T., Takaki M., Nagatomo K., Nakajima A., Willmore L.J. Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy. Brain Res 2009, 1266:1-7.
53. van Eijsden P., Notenboom R.G., Wu O., de Graan P.N., van Nieuwenhuizen O., Nicolay K. In vivo 1H magnetic resonance spectroscopy, T2-weighted and diffusion-weighted MRI during lithium-pilocarpine-induced status epilepticus in the rat. Braun KP. Brain Res 2004, 1030:11-18.
54. van Vliet E.A., van Schaik R., Edelbroek P.M., da Silva F.H., Wadman W.J., Gorter J.A. Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia 2008, 49:1151-1159.
55. VanLandingham K.E., Heinz E.R., Cavazos J.E., Lewis D.V. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998, 43:413-426.
56. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008, 49:8-21.
57. Zheng Y., Moussally J., Cash S.S., Karnam H.B., Cole A.J. Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies. Neuropharmacology 2010, 58:793-798.